Illustrating Emerging Good Practices for Quantitative Benefit-Risk Assessment: A Hypothetical Case Study of Systemic Biologic Treatments for Plaque Psoriasis.
Value Health
; 26(4): 519-527, 2023 04.
Article
in En
| MEDLINE
| ID: mdl-36764517
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Psoriasis
/
Biological Products
Type of study:
Clinical_trials
/
Etiology_studies
/
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Humans
Language:
En
Journal:
Value Health
Journal subject:
FARMACOLOGIA
Year:
2023
Document type:
Article
Country of publication: